Filtered Listing Testing

Newsletters

The spring edition of our macular degeneration research newsletter explores new treatments that are on the horizon, what to expect when it comes to injections, and more.

Mar 28, 2016
Research News
Research funded by BrightFocus Foundation could lead to new drugs and therapies that prevent vision loss in glaucoma more effectively than pressure-lowering treatments alone.
Mar 24, 2016
In exciting new BrightFocus-funded animal research, scientists are getting closer to replacing damaged retinal cells and rewiring the eye-brain connection.
Mar 9, 2016
Kristine Yaffe, MD, is a recognized expert on the art of maintaining cognitive health as our brains age.
Mar 3, 2016
Newsletters

Learn about research exploring the mechanisms of eye pressure regulation, which could lead to improved glaucoma treatments, five tips for using glaucoma eye drops, information about childhood glaucoma, and more in the winter edition of the winter edition of our glaucoma newsletter.

Feb 25, 2016

Learn about an encouraging breakthrough for future Alzheimer's treatment, how it may be possible to “recruit” fresh immune cells to replace or invigorate the brain’s existing immune cells that have become depleted and flawed during the preclinical stage of Alzheimer’s, tips for fighting Alzheimer's, and more in the winter edition of our Alzheimer's disease newsletter.

Feb 25, 2016
Research News

Time magazine recently described a “cocktail” approach to fighting Alzheimer’s. BrightFocus-funded research supports this effort, which takes us closer to a cure.

Feb 18, 2016
BrightFocus expert contributor, Yvonne Ou, MD, weighs in on eye drops, conventional surgery, and laser as treatment options in glaucoma. Read our Q and A.
Jan 29, 2016

BrightFocus grantee Rik Ossenkoppele, PhD, of Vrije Universiteit (VU) Medical Center, Amsterdam, wins the Young Investigator Award at the 2016 Human Amyloid Imaging (HAI) Conference. Read more...

Jan 29, 2016
Learn about an exciting gene editing technique that may one day be used in combination with cell regeneration to correct a genetic mutation leading to blindness.
Jan 27, 2016